Skip to Content

GX LL7 (Lexiva 700 mg)

Generic Name: fosamprenavir

Pill with imprint GX LL7 is Pink, Capsule-shape and has been identified as Lexiva 700 mg. It is supplied by GlaxoSmithKline.

Lexiva is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class protease inhibitors. Risk cannot be ruled out during pregnancy. Lexiva 700 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GX LL7

Lexiva 700 mg GX LL7
Lexiva 700 mg GX LL7
Lexiva 700 mg GX LL7

Lexiva

Generic Name
fosamprenavir
Imprint
GX LL7
Strength
700 mg
Color
Pink
Size
21.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Protease inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
GlaxoSmithKline
National Drug Code (NDC)
00173-0721

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.